Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 3184

1.

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection.

Mallajosyula VV, Citron M, Ferrara F, Lu X, Callahan C, Heidecker GJ, Sarma SP, Flynn JA, Temperton NJ, Liang X, Varadarajan R.

Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2514-23. doi: 10.1073/pnas.1402766111. Epub 2014 Jun 9.

PMID:
24927560
[PubMed - indexed for MEDLINE]
2.

PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine.

Rioux G, Mathieu C, Russell A, Bolduc M, Laliberté-Gagné ME, Savard P, Leclerc D.

J Nanobiotechnology. 2014 May 3;12:19. doi: 10.1186/1477-3155-12-19.

PMID:
24885884
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.

Matsuoka Y, Suguitan A Jr, Orandle M, Paskel M, Boonnak K, Gardner DJ, Feldmann F, Feldmann H, Marino M, Jin H, Kemble G, Subbarao K.

J Virol. 2014 Jul;88(14):8139-52. doi: 10.1128/JVI.00425-14. Epub 2014 May 7.

PMID:
24807726
[PubMed - indexed for MEDLINE]
4.

Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.

Pouwels HG, Van de Zande SM, Horspool LJ, Hoeijmakers MJ.

Vet Rec. 2014 Jun 21;174(25):633. doi: 10.1136/vr.101993. Epub 2014 May 2.

PMID:
24795071
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection].

Sergeeva MV, Kuznetsov VV, Kas'ianenko MA, Shaldzhian AA, Repko IA, Potapchuk MV, Romanova IuR, Tsybalova LM.

Vopr Virusol. 2013 Nov-Dec;58(6):36-9. Russian.

PMID:
24772645
[PubMed - indexed for MEDLINE]
6.

[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].

Smolonogina TA, Desheva IuA, Rekstin AR, Mironov AN, Rudenko LG.

Vopr Virusol. 2013 Nov-Dec;58(6):31-5. Russian.

PMID:
24772644
[PubMed - indexed for MEDLINE]
7.

Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination.

O E, Lee YT, Ko EJ, Kim KH, Lee YN, Song JM, Kwon YM, Kim MC, Perez DR, Kang SM.

J Virol. 2014 Jul;88(14):7764-75. doi: 10.1128/JVI.00748-14. Epub 2014 Apr 23.

PMID:
24760891
[PubMed - indexed for MEDLINE]
8.

Essential role for autophagy in the maintenance of immunological memory against influenza infection.

Chen M, Hong MJ, Sun H, Wang L, Shi X, Gilbert BE, Corry DB, Kheradmand F, Wang J.

Nat Med. 2014 May;20(5):503-10. doi: 10.1038/nm.3521. Epub 2014 Apr 20.

PMID:
24747745
[PubMed - indexed for MEDLINE]
9.

The antigenic drift molecular basis of the H5N1 influenza viruses in a novel branch of clade 2.3.4.

Zhong L, Zhao Q, Zhao K, Wang X, Zhao G, Li Q, Gu M, Peng D, Liu X.

Vet Microbiol. 2014 Jun 25;171(1-2):23-30. doi: 10.1016/j.vetmic.2014.02.033. Epub 2014 Mar 2.

PMID:
24745625
[PubMed - indexed for MEDLINE]
10.

Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.

Tabynov K, Sansyzbay A, Kydyrbayev Z, Yespembetov B, Ryskeldinova S, Zinina N, Assanzhanova N, Sultankulova K, Sandybayev N, Khairullin B, Kuznetsova I, Ferko B, Egorov A.

Virol J. 2014 Apr 10;11:69. doi: 10.1186/1743-422X-11-69.

PMID:
24716528
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection.

Valkenburg SA, Li OT, Mak PW, Mok CK, Nicholls JM, Guan Y, Waldmann TA, Peiris JS, Perera LP, Poon LL.

Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5676-81. doi: 10.1073/pnas.1403684111. Epub 2014 Mar 31.

PMID:
24706798
[PubMed - indexed for MEDLINE]
12.

Stability of neuraminidase in inactivated influenza vaccines.

Sultana I, Yang K, Getie-Kebtie M, Couzens L, Markoff L, Alterman M, Eichelberger MC.

Vaccine. 2014 Apr 17;32(19):2225-30. doi: 10.1016/j.vaccine.2014.01.078. Epub 2014 Mar 6.

PMID:
24613525
[PubMed - indexed for MEDLINE]
13.

Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy.

Teijaro JR, Walsh KB, Long JP, Tordoff KP, Stark GV, Eisfeld AJ, Kawaoka Y, Rosen H, Oldstone MB.

Virology. 2014 Mar;452-453:152-7. doi: 10.1016/j.virol.2014.01.003. Epub 2014 Jan 31.

PMID:
24606692
[PubMed - indexed for MEDLINE]
14.

A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.

Talaat KR, Luke CJ, Khurana S, Manischewitz J, King LR, McMahon BA, Karron RA, Lewis KD, Qin J, Follmann DA, Golding H, Neuzil KM, Subbarao K.

J Infect Dis. 2014 Jun 15;209(12):1860-9. doi: 10.1093/infdis/jiu123. Epub 2014 Mar 5.

PMID:
24604819
[PubMed - indexed for MEDLINE]
15.

Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.

Tabynov K, Kydyrbayev Z, Ryskeldinova S, Yespembetov B, Zinina N, Assanzhanova N, Kozhamkulov Y, Inkarbekov D, Gotskina T, Sansyzbay A.

Vaccine. 2014 Apr 11;32(18):2034-41. doi: 10.1016/j.vaccine.2014.02.058. Epub 2014 Mar 2.

PMID:
24598723
[PubMed - indexed for MEDLINE]
Free Article
16.

Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans.

Morokutti A, Muster T, Ferko B.

Vaccine. 2014 Apr 7;32(17):1897-900. doi: 10.1016/j.vaccine.2014.02.009. Epub 2014 Feb 22.

PMID:
24560674
[PubMed - indexed for MEDLINE]
17.

High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination.

Tan YC, Blum LK, Kongpachith S, Ju CH, Cai X, Lindstrom TM, Sokolove J, Robinson WH.

Clin Immunol. 2014 Mar;151(1):55-65. doi: 10.1016/j.clim.2013.12.008. Epub 2014 Jan 9.

PMID:
24525048
[PubMed - indexed for MEDLINE]
18.

Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice.

Chowdhury MY, Seo SK, Moon HJ, Talactac MR, Kim JH, Park ME, Son HY, Lee JS, Kim CJ.

Virol J. 2014 Feb 6;11:21. doi: 10.1186/1743-422X-11-21.

PMID:
24502341
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.

Whittle JR, Wheatley AK, Wu L, Lingwood D, Kanekiyo M, Ma SS, Narpala SR, Yassine HM, Frank GM, Yewdell JW, Ledgerwood JE, Wei CJ, McDermott AB, Graham BS, Koup RA, Nabel GJ.

J Virol. 2014 Apr;88(8):4047-57. doi: 10.1128/JVI.03422-13. Epub 2014 Feb 5.

PMID:
24501410
[PubMed - indexed for MEDLINE]
20.

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.

Tinoco JC, Pavia-Ruz N, Cruz-Valdez A, Aranza Doniz C, Chandrasekaran V, Dewé W, Liu A, Innis BL, Jain VK.

Vaccine. 2014 Mar 14;32(13):1480-7. doi: 10.1016/j.vaccine.2014.01.022. Epub 2014 Jan 28.

PMID:
24486352
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk